SEC Company Response from Neurogene Inc. (NGNE) (CIK 0001404644) (NGNE) — Apr 2, 2025
Neurogene Inc. (NGNE) (CIK 0001404644)
Date: April 2, 2025 · CIK: 0001404644 · Accession: 0001628280-25-016058
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286057
Letter
Document April 2, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Joshua Gorsky Re: Neurogene Inc. Registration Statement on Form S-3 (File No. 333-286057) Ladies and Gentlemen: Neurogene Inc. hereby respectfully requests that, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the effectiveness of the above-referenced Registration Statement on Form S-3 be accelerated so that it will become effective on April 4, 2025, at 4:15 p.m., Eastern Time, or as soon as practicable thereafter, unless we or our outside counsel, Gibson, Dunn & Crutcher LLP, request by telephone that such Registration Statement be declared effective at some other time. We request that we be notified of such effectiveness by a telephone call to Branden C. Berns of Gibson, Dunn & Crutcher at (415) 393-4631. Sincerely, NEUROGENE INC. By: /s/ Christine Mikail Christine Mikail President and Chief Financial Officer cc: Donna Cochener, Neurogene Inc. Ryan A. Murr, Gibson, Dunn & Crutcher LLP Branden C. Berns, Gibson, Dunn & Crutcher LLP
Show Raw Text
CORRESP 1 filename1.htm Document April 2, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Joshua Gorsky Re: Neurogene Inc. Registration Statement on Form S-3 (File No. 333-286057) Ladies and Gentlemen: Neurogene Inc. hereby respectfully requests that, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the effectiveness of the above-referenced Registration Statement on Form S-3 be accelerated so that it will become effective on April 4, 2025, at 4:15 p.m., Eastern Time, or as soon as practicable thereafter, unless we or our outside counsel, Gibson, Dunn & Crutcher LLP, request by telephone that such Registration Statement be declared effective at some other time. We request that we be notified of such effectiveness by a telephone call to Branden C. Berns of Gibson, Dunn & Crutcher at (415) 393-4631. Sincerely, NEUROGENE INC. By: /s/ Christine Mikail Christine Mikail President and Chief Financial Officer cc: Donna Cochener, Neurogene Inc. Ryan A. Murr, Gibson, Dunn & Crutcher LLP Branden C. Berns, Gibson, Dunn & Crutcher LLP